Steve Fruchtman | CEO |
Mark Guerin | CFO |
Mark Gelder | Chief Medical Officer |
Avi Oler | Senior Vice President |
Steve Cosenza | Senior Scientist |
Dr. Charles Zhu | Guggenheim Securities |
Matt | H.C. Wainwright |
Robert LeBoyer | NOBLE Capital |
Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics Third Quarter 2021 Financial Results and Business Update Conference Call. At this time. All participants are in a listen-only mode.
Following management's prepared remarks, we will hold a Q&A session.